{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:41:19Z","timestamp":1793914879651,"version":"4.8.0"},"reference-count":171,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"vor","delay-in-days":123,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","cmghjournal.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.jcmgh.2024.05.003","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T02:22:14Z","timestamp":1715221334000},"page":"101355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Interplay Between Drug-Induced Liver Injury and Gut Microbiota: A Comprehensive Overview"],"prefix":"10.1016","volume":"18","author":[{"given":"Guolin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifu","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changji","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furong","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5354-0420","authenticated-orcid":false,"given":"Dongke","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2024.05.003_bib1","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/liv.15262","article-title":"Incidence and risk factors of drug-induced liver injury","volume":"42","author":"Li","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/jhep.2002.34857","article-title":"Incidence of drug-induced hepatic injuries: a French population-based study","volume":"36","author":"Sgro","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib3","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s40264-017-0547-9","article-title":"The incidence of drug- and herbal and dietary supplement-induced liver injury: preliminary findings from gastroenterologist-based surveillance in the population of the state of Delaware","volume":"40","author":"Vega","year":"2017","journal-title":"Drug Saf"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib4","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1053\/j.gastro.2019.02.002","article-title":"Incidence and etiology of drug-induced liver injury in mainland China","volume":"156","author":"Shen","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib5","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1053\/j.gastro.2013.02.006","article-title":"Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland","volume":"144","author":"Bj\u00f6rnsson","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006558","article-title":"Suboptimal community growth mediated through metabolite crossfeeding promotes species diversity in the gut microbiota","volume":"14","author":"Henson","year":"2018","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature11234","article-title":"Structure, function and diversity of the healthy human microbiome","volume":"486","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib8","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.3390\/nu11102393","article-title":"Food components and dietary habits: keys for a healthy gut microbiota composition","volume":"11","author":"Rinninella","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib9","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/sj.embor.7400731","article-title":"The gut flora as a forgotten organ","volume":"7","author":"O\u2019Hara","year":"2006","journal-title":"EMBO Rep"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00338-20","article-title":"A\u00a0comprehensive review on the role of the gut microbiome in human neurological disorders","volume":"35","author":"Sorboni","year":"2022","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/nu14010103","article-title":"Metabolic-associated fatty liver disease (MAFLD), diabetes, and cardiovascular disease: associations with fructose metabolism and gut microbiota","volume":"14","author":"Dro\u017cd\u017c","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.943408","article-title":"The relationships between the gut microbiota and its metabolites with thyroid diseases","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib13","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.hbpd.2023.06.008","article-title":"Contribution of gut microbiota to drug-induced liver injury","volume":"22","author":"Chu","year":"2023","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib14","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1194\/jlr.R036012","article-title":"The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism","volume":"54","author":"den Besten","year":"2013","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jnutbio.2018.10.003","article-title":"Gut microbiome and type 2 diabetes: where we are and where to go?","volume":"63","author":"Sharma","year":"2019","journal-title":"J\u00a0Nutr Biochem"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40168-017-0240-3","article-title":"Erratum to: Evolution of gut microbiota composition from birth to 24 weeks in the INFANTMET cohort","volume":"5","author":"Hill","year":"2017","journal-title":"Microbiome"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01596-21","article-title":"Akkermansia muciniphila ameliorates acetaminophen-induced liver injury by regulating gut microbial composition and metabolism","volume":"10","author":"Xia","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib18","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.transproceed.2016.01.077","article-title":"Profile of gut microbiota associated with the presence of hepatocellular cancer in patients with liver cirrhosis","volume":"48","author":"Gr\u0105t","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jhep.2018.02.024","article-title":"Gut microbiota mediates diurnal variation of acetaminophen induced acute liver injury in mice","volume":"69","author":"Gong","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib20","article-title":"Gut microbiota and chemical-induced acute liver injury","volume":"12","author":"Chen","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib21","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1007\/s00204-020-02885-1","article-title":"Drug induced liver injury: an update","volume":"94","author":"Garcia-Cortes","year":"2020","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib23","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","article-title":"Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States","volume":"137","author":"Ostapowicz","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib24","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1038\/ajg.2010.287","article-title":"Single-center experience with drug-induced liver injury from India: causes, outcome, prognosis, and predictors of mortality","volume":"105","author":"Devarbhavi","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib25","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","article-title":"Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study","volume":"148","author":"Chalasani","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib26","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1056\/NEJMra1816149","article-title":"Drug-induced liver injury - types and phenotypes","volume":"381","author":"Hoofnagle","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2021.126707","article-title":"Gut microbiota exaggerates triclosan-induced liver injury via gut-liver axis","volume":"421","author":"Zhang","year":"2022","journal-title":"J\u00a0Hazard Mater"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib29","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/hep.31228","article-title":"Intestinal microbiome-macrophage crosstalk contributes to cholestatic liver disease by promoting intestinal permeability in mice","volume":"72","author":"Isaacs-Ten","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.598170","article-title":"Gut microbiota participates in antithyroid drug induced liver injury through the lipopolysaccharide related signaling pathway","volume":"11","author":"Sun","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib31","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1016\/j.cgh.2018.12.013","article-title":"Patients with chronic liver disease suggestive of nonalcoholic fatty liver disease may be at higher risk for drug-induced liver injury","volume":"17","author":"Lammert","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib32","first-page":"790","article-title":"Clinical and genetic risk factors for drug-induced liver injury associated with anti-tuberculosis treatment-a study from patients of Portuguese health centers","volume":"12","author":"Cavaco","year":"2022","journal-title":"J\u00a0Pers Med"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib33","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8811021","article-title":"Scutellarein aggravated carbon tetrachloride-induced chronic liver injury in gut microbiota-dysbiosis mice","volume":"2020","author":"Miao","year":"2020","journal-title":"Evid-Based Complement Alternat Med"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftaa041","article-title":"Hepatic dysfunction induced by intestinal dysbacteriosis mainly manifests as immunologic abnormity in mice","volume":"78","author":"Luo","year":"2020","journal-title":"Pathog Dis"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12967-021-02814-5","article-title":"Gut microbiota accelerates cisplatin-induced acute liver injury associated with robust inflammation and oxidative stress in mice","volume":"19","author":"Gong","year":"2021","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib36","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.4155\/fmc-2020-0023","article-title":"The central role of gut microbiota in drug metabolism and personalized medicine","volume":"12","author":"Colotti","year":"2020","journal-title":"Future Med Chem"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib37","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/joim.12508","article-title":"The gut microbiota and metabolic disease: current understanding and future perspectives","volume":"280","author":"Arora","year":"2016","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib38","doi-asserted-by":"crossref","first-page":"852","DOI":"10.3390\/metabo11120852","article-title":"Targeted metabolomics analysis of bile acids in patients with idiosyncratic drug-induced liver injury","volume":"11","author":"Xie","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib39","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016717","article-title":"Serum metabolome and targeted bile acid profiling reveals potential novel biomarkers for drug-induced liver injury","volume":"98","author":"Ma","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib41","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.jhep.2015.08.001","article-title":"Implications of microbiota and bile acid in liver injury and regeneration","volume":"63","author":"Liu","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104752","article-title":"Gut microbiota protects from triptolide-induced hepatotoxicity: key role of propionate and its downstream signalling events","volume":"155","author":"Huang","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib43","article-title":"Alteration of bile acids and omega-6 PUFAs are correlated with the progression and prognosis of drug-induced liver injury","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib44","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11154-019-09512-0","article-title":"Dietary lipids, gut microbiota and lipid metabolism","volume":"20","author":"Schoeler","year":"2019","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2021.153088","article-title":"Elemicin exposure induced aberrant lipid metabolism via modulation of gut microbiota in mice","volume":"467","author":"Zhang","year":"2022","journal-title":"Toxicology"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2020.114844","article-title":"Effects of difenoconazole on hepatotoxicity, lipid metabolism and gut microbiota in zebrafish (Danio rerio)","volume":"265","author":"Jiang","year":"2020","journal-title":"Environ Pollut"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib47","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9302733","article-title":"Moxifloxacin induced liver injury by causing lachnospiraceae deficiency and interfering with butyric acid production through gut-liver axis","volume":"2022","author":"Sun","year":"2022","journal-title":"Dis Markers"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib48","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s12272-012-0418-y","article-title":"Role of metabolism by human intestinal microflora in geniposide-induced toxicity in HepG2 cells","volume":"35","author":"Kang","year":"2012","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib49","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/hep.29327","article-title":"The liver-gut microbiota axis modulates hepatotoxicity of tacrine in the rat","volume":"67","author":"Yip","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41575-018-0061-2","article-title":"You are what you eat: diet, health and the gut microbiota","volume":"16","author":"Zmora","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib51","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.chom.2023.04.002","article-title":"Liberation of daidzein by gut microbial \u03b2-galactosidase suppresses acetaminophen-induced hepatotoxicity in mice","volume":"31","author":"Zeng","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib52","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1124\/pr.118.015768","article-title":"Gut reactions: breaking down xenobiotic-microbiome interactions","volume":"71","author":"Clarke","year":"2019","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib53","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature15766","article-title":"Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota","volume":"528","author":"Forslund","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib54","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1053\/j.gastro.2015.06.043","article-title":"Proton pump inhibitors alter specific taxa in the human gastrointestinal microbiome: a crossover trial","volume":"149","author":"Freedberg","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib55","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1126\/science.aad3369","article-title":"Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity","volume":"352","author":"Zhernakova","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib56","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1038\/s41467-018-05184-7","article-title":"Gut microbiota associations with common diseases and prescription medications in a population-based cohort","volume":"9","author":"Jackson","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib57","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41467-019-14177-z","article-title":"Impact of commonly used drugs on the composition and metabolic function of the gut microbiota","volume":"11","author":"Vich Vila","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib58","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13073-016-0295-y","article-title":"The influence of a short-term gluten-free diet on the human gut microbiome","volume":"8","author":"Bonder","year":"2016","journal-title":"Genome Med"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib59","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1126\/science.aad3503","article-title":"Population-level analysis of gut microbiome variation","volume":"352","author":"Falony","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib60","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrmicro.2017.44","article-title":"Anticancer effects of the microbiome and its products","volume":"15","author":"Zitvogel","year":"2017","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib61","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41586-019-1291-3","article-title":"Mapping human microbiome drug metabolism by gut bacteria and their genes","volume":"570","author":"Zimmermann","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib62","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat9931","article-title":"Separating host and microbiome contributions to drug pharmacokinetics and toxicity","volume":"363","author":"Zimmermann","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib63","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/gutjnl-2019-320204","article-title":"Interaction between drugs and the gut microbiome","volume":"69","author":"Weersma","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib64","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nature25979","article-title":"Extensive impact of non-antibiotic drugs on human gut bacteria","volume":"555","author":"Maier","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib65","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6323","article-title":"Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism","volume":"364","author":"Maini Rekdal","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib66","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41467-019-08294-y","article-title":"Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson\u2019s disease","volume":"10","author":"van Kessel","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib68","first-page":"1169","article-title":"Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method","volume":"14","author":"Teschke","year":"2018","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib69","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/01.meg.0000250581.77865.68","article-title":"Antibiotic therapy: a major cause of drug-induced jaundice in southwest England","volume":"19","author":"Hussaini","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib70","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.3390\/ijms23094828","article-title":"Liver injury in COVID-19 patients with drugs as causatives: a systematic review of 996 DILI cases published 2020\/2021 based on RUCAM as causality assessment method","volume":"23","author":"Teschke","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib71","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.celrep.2016.01.009","article-title":"Host-microbiota interactions in the pathogenesis of antibiotic-associated diseases","volume":"14","author":"Lichtman","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib72","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpeds.2014.01.010","article-title":"Early empiric antibiotic use in preterm infants is associated with lower bacterial diversity and higher relative abundance of Enterobacter","volume":"165","author":"Greenwood","year":"2014","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib73","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1038\/s41591-020-1102-2","article-title":"Acute liver failure is regulated by MYC- and microbiome-dependent programs","volume":"26","author":"Kolodziejczyk","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib74","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jpha.2019.11.003","article-title":"Vancomycin pretreatment attenuates acetaminophen-induced liver injury through 2-hydroxybutyric acid","volume":"10","author":"Zheng","year":"2020","journal-title":"J\u00a0Pharm Anal"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144854","article-title":"Antibiotic treatment affects intestinal permeability and gut microbial composition in Wistar rats dependent on antibiotic class","volume":"10","author":"Tulstrup","year":"2015","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"10.1016\/j.jcmgh.2024.05.003_bib77","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1073\/pnas.1000087107","article-title":"Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation","volume":"108","author":"Dethlefsen","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib78","first-page":"471","article-title":"The effect of antibiotics on the composition of the intestinal microbiota - a systematic review","volume":"79","author":"Zimmermann","year":"2019","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib98","article-title":"The immunotoxicity, but not anti-tumor efficacy, of anti-CD40 and anti-CD137 immunotherapies is dependent on the gut microbiota","volume":"2","author":"Blake","year":"2021","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib99","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/s42003-021-02883-8","article-title":"Hepatoprotective effects of Cassiae Semen on mice with non-alcoholic fatty liver disease based on gut microbiota","volume":"4","author":"Luo","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib100","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1002\/ctm2.112","article-title":"Modulation of gut microbiota mediates berberine-induced expansion of immuno-suppressive cells to against alcoholic liver disease","volume":"10","author":"Li","year":"2020","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib101","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1038\/s41598-019-41295-x","article-title":"N-(1-carbamoyl-2-phenylethyl) butyramide reduces antibiotic-induced intestinal injury, innate immune activation and modulates microbiota composition","volume":"9","author":"Lama","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib102","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1017\/S0007114519001466","article-title":"The effects of antibiotics and melatonin on hepato-intestinal inflammation and gut microbial dysbiosis induced by a short-term high-fat diet consumption in rats","volume":"122","author":"Yildirim","year":"2019","journal-title":"Br J Nutr"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib79","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/1471-0528.15799","article-title":"Specific class of intrapartum antibiotics relates to maturation of the infant gut microbiota: a prospective cohort study","volume":"127","author":"Coker","year":"2020","journal-title":"BJOG"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib80","doi-asserted-by":"crossref","first-page":"131","DOI":"10.32628\/IJSRST207619","article-title":"Comparing cefixime, cefpodoxime and ofloxacin as anti-microbial agents and their effects on gut microbiota","volume":"7","author":"Singh","year":"2020","journal-title":"Int J Sci Res Sci Technol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib81","article-title":"Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia","volume":"7","author":"Xue","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib82","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.taap.2014.03.009","article-title":"Effect of various antibiotics on modulation of intestinal microbiota and bile acid profile in mice","volume":"277","author":"Zhang","year":"2014","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib83","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000000661","article-title":"Longitudinal analysis of the intestinal microbiota in liver transplantation","volume":"3","author":"Kato","year":"2017","journal-title":"Transplant Direct"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib84","doi-asserted-by":"crossref","first-page":"11546","DOI":"10.1080\/21655979.2021.2009966","article-title":"Gastrodin attenuates perfluorooctanoic acid-induced liver injury by regulating gut microbiota composition in mice","volume":"12","author":"Ma","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib85","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.foodres.2016.12.008","article-title":"The modulatory effect of (-)-epigallocatechin 3-O-(3-O-methyl) gallate (EGCG3\u2033Me) on intestinal microbiota of high fat diet-induced obesity mice model","volume":"92","author":"Cheng","year":"2017","journal-title":"Food Res Int"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib86","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jhep.2012.06.011","article-title":"Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats","volume":"57","author":"Zhang","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib87","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2133\/dmpk.24.201","article-title":"Ciprofloxacin suppresses Cyp3a in mouse liver by reducing lithocholic acid-producing intestinal flora","volume":"24","author":"Toda","year":"2009","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib88","article-title":"Trimethylamine-N-oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: a randomized controlled trial","volume":"61","author":"Cho","year":"2017","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib89","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/jcph.2059","article-title":"Drug-drug interactions and disease status are associated with irinotecan-induced hepatotoxicity: a cross-sectional study in Shanghai","volume":"62","author":"Li","year":"2022","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.715577","article-title":"Evaluation of a clinically relevant drug-drug interaction between rosuvastatin and clopidogrel and the risk of hepatotoxicity","volume":"12","author":"Ning","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib91","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1124\/dmd.114.058354","article-title":"Gut microbiota-mediated drug interactions between lovastatin and antibiotics","volume":"42","author":"Yoo","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib92","first-page":"S603","article-title":"Association of hypercholesterolemia or hypertriglyceridemia with degree of hepatic steatosis in patients with non-alcoholic fatty liver disease","volume":"46","author":"Razmpour","year":"2021","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib93","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fvets.2015.00057","article-title":"Regulation of the intestinal barrier function by host defense peptides","volume":"2","author":"Robinson","year":"2015","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib94","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jep.2015.12.031","article-title":"Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?","volume":"179","author":"Chen","year":"2016","journal-title":"J\u00a0Ethnopharmacol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib95","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/nu7010017","article-title":"The impact of diet and lifestyle on gut microbiota and human health","volume":"7","author":"Conlon","year":"2014","journal-title":"Nutrients"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib96","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.celrep.2018.03.109","article-title":"Gut microbiota-derived tryptophan metabolites modulate inflammatory response in hepatocytes and macrophages","volume":"23","author":"Krishnan","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib97","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3748\/wjg.15.1677","article-title":"Bile-acid-induced cell injury and protection","volume":"15","author":"Perez","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib103","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.gtc.2016.09.007","article-title":"The microbiome-gut-brain axis in health and disease","volume":"46","author":"Dinan","year":"2017","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib104","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ebiom.2019.05.024","article-title":"The gut microbiome and epilepsy","volume":"44","author":"Dahlin","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib105","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","article-title":"The microbiota-gut-brain axis","volume":"99","author":"Cryan","year":"2019","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib106","first-page":"223","article-title":"Feeding the microbiota-gut-brain axis: diet, microbiome, and neuropsychiatry","volume":"179","author":"Sandhu","year":"2017","journal-title":"Transl Res J Lab Clin Med"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib107","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.drudis.2019.09.022","article-title":"Drug-induced liver injury severity and toxicity (DILIst): binary classification of 1279 drugs by human hepatotoxicity","volume":"25","author":"Thakkar","year":"2020","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib108","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s40264-017-0583-5","article-title":"Antidepressant-induced acute liver injury: a case-control study in an Italian inpatient population","volume":"41","author":"Ferrajolo","year":"2018","journal-title":"Drug Saf"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib109","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1055\/a-1071-8028","article-title":"Drug-induced liver injury (DILI) in patients with depression treated with antidepressants: a retrospective multicenter study","volume":"53","author":"Ueberberg","year":"2020","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib110","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.cgh.2016.05.033","article-title":"Similar fecal microbiota signatures in patients with diarrhea-predominant irritable bowel syndrome and patients with depression","volume":"14","author":"Liu","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib111","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/WNR.0000000000000985","article-title":"Comparative metaproteomics analysis shows altered fecal microbiota signatures in patients with major depressive disorder","volume":"29","author":"Chen","year":"2018","journal-title":"Neuroreport"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib112","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jpba.2017.02.008","article-title":"Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16S rRNA gene sequencing and LC\/MS-based metabolomics","volume":"138","author":"Yu","year":"2017","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib113","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbi.2015.03.016","article-title":"Altered fecal microbiota composition in patients with major depressive disorder","volume":"48","author":"Jiang","year":"2015","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib114","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1590\/S1517-83822010000300014","article-title":"An investigation on in\u00a0vitro and in\u00a0vivo antimicrobial properties of the antidepressant: amitriptyline hydrochloride","volume":"41","author":"Mandal","year":"2010","journal-title":"Braz J Microbiol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib115","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0140-6736(90)90034-3","article-title":"Desipramine reversal of chloroquine resistance in wild isolates of Plasmodium falciparum","volume":"335","author":"Salama","year":"1990","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib116","first-page":"2267","article-title":"Mechanism of action of tricyclic drugs on Escherichia coli and Yersinia enterocolitica plasmid maintenance and replication","volume":"12","author":"Csiszar","year":"1992","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib117","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/jac\/37.5.1005","article-title":"In-vitro activity of psychiatric drugs against Corynebacterium urealyticum (Corynebacterium group D2)","volume":"37","author":"Mu\u00f1oz-Bellido","year":"1996","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib118","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1128\/AAC.35.10.2140","article-title":"In\u00a0vitro activity of 79 antimicrobial agents against Corynebacterium group D2","volume":"35","author":"Garc\u00eda-Rodriguez","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib119","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/BF01690103","article-title":"In\u00a0vitro activity of nonsteroidal anti-inflammatory agents, phenotiazines, and antidepressants against Brucella species","volume":"15","author":"Mu\u00f1oz-Criado","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib120","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1093\/jac\/dkr258","article-title":"Efflux inhibition by selective serotonin reuptake inhibitors in Escherichia coli","volume":"66","author":"Bohnert","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib121","first-page":"4","article-title":"Sertraline enhances the activity of antimicrobial agents against pathogens of clinical relevance","volume":"22","author":"Ayaz","year":"2015","journal-title":"J\u00a0Biol Res (Thessalon)"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib122","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1574-695X.2003.tb00643.x","article-title":"Interaction of sertraline with Candida species selectively attenuates fungal virulence in\u00a0vitro","volume":"35","author":"Lass-Fl\u00f6rl","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib123","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s12223-016-0449-8","article-title":"In\u00a0vitro synergistic effects of chlorpromazine and sertraline in combination with amphotericin B against Cryptococcus neoformans var. grubii","volume":"61","author":"Rossato","year":"2016","journal-title":"Folia Microbiol (Praha)"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib124","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/mmy\/myv109","article-title":"Activity of sertraline against Cryptococcus neoformans: in\u00a0vitro and in\u00a0vivo assays","volume":"54","author":"Trevi\u00f1o-Rangel","year":"2016","journal-title":"Med Mycol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib125","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1128\/AAC.00212-12","article-title":"The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections","volume":"56","author":"Zhai","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib126","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/21501203.2016.1204368","article-title":"Sertraline demonstrates fungicidal activity in\u00a0vitro for Coccidioides immitis","volume":"7","author":"Paul","year":"2016","journal-title":"Mycology"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib127","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s00213-018-5006-5","article-title":"Differential effects of psychotropic drugs on microbiome composition and gastrointestinal function","volume":"236","author":"Cussotto","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib128","first-page":"58","article-title":"Observation on the effect and mechanism of bifidobacterium triple live bacteria assisting paroxetine in the treatment of female patients with depression","volume":"60","author":"An","year":"2020","journal-title":"Shandong Med J"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib129","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1055\/s-2002-30105","article-title":"Epidemiology and individual susceptibility to adverse drug reactions affecting the liver","volume":"22","author":"Larrey","year":"2002","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib130","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/clinchem\/34.5.890","article-title":"Valproic acid and the liver","volume":"34","author":"Cotariu","year":"1988","journal-title":"Clin Chem"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib131","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1111\/j.1528-1167.2006.00846.x","article-title":"Valproic acid-induced hepatopathy: nine new fatalities in Germany from 1994 to 2003","volume":"47","author":"Koenig","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib132","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/WNL.46.2.465","article-title":"Valproic acid hepatic fatalities. III. U.S. experience since 1986","volume":"46","author":"Bryant","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib133","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1212\/WNL.37.3.379","article-title":"Valproic acid hepatic fatalities: a retrospective review","volume":"37","author":"Dreifuss","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib134","first-page":"63","article-title":"Non-fatal and fatal liver failure associated with valproic acid","volume":"46","author":"Schmid","year":"2013","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib135","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0022-3476(80)80123-5","article-title":"The effects of phenobarbital and diphenylhydantoin on liver function and morphology","volume":"97","author":"Aiges","year":"1980","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib136","doi-asserted-by":"crossref","first-page":"724","DOI":"10.7326\/M15-2211","article-title":"Outcomes in adults with acute liver failure between 1998 and 2013: an observational cohort study","volume":"164","author":"Reuben","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib137","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/hep.20948","article-title":"Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study","volume":"42","author":"Larson","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib138","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s00134-014-3293-9","article-title":"Understanding paracetamol-induced liver failure","volume":"40","author":"Larsen","year":"2014","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib139","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/hep.20293","article-title":"Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure","volume":"40","author":"Lee","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib140","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fgene.2014.00314","article-title":"Pharmacogenomics of acetaminophen in pediatric populations: a moving target","volume":"5","author":"Krasniak","year":"2014","journal-title":"Front Genet"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib141","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1159\/000354449","article-title":"Acetaminophen changes intestinal epithelial cell membrane properties, subsequently affecting absorption processes","volume":"32","author":"Sch\u00e4fer","year":"2013","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib142","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1080\/01480545.2016.1255953","article-title":"Acetaminophen toxicity in rat and mouse hepatocytes in\u00a0vitro","volume":"40","author":"Ku\u010dera","year":"2017","journal-title":"Drug Chem Toxicol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib143","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1053\/j.gastro.2019.04.023","article-title":"Endoplasmic reticulum stress-induced upregulation of STARD1 promotes acetaminophen-induced acute liver failure","volume":"157","author":"Torres","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib144","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s40262-015-0357-0","article-title":"Morbidly obese patients exhibit increased CYP2E1-mediated oxidation of acetaminophen","volume":"55","author":"van Rongen","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.taap.2010.04.015","article-title":"c-Jun N-terminal kinase modulates oxidant stress and peroxynitrite formation independent of inducible nitric oxide synthase in acetaminophen hepatotoxicity","volume":"246","author":"Saito","year":"2010","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib146","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182977","article-title":"Fructose diet\u00a0alleviates acetaminophen-induced hepatotoxicity in mice","volume":"12","author":"Cho","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib147","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-0038-1651492","article-title":"Global epidemiology of tuberculosis","volume":"39","author":"Glaziou","year":"2018","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib148","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1080\/00498254.2022.2092783","article-title":"Relevance of gene polymorphisms of NAT2 and NR1I2 to anti-tuberculosis drug-induced hepatotoxicity","volume":"52","author":"Wang","year":"2022","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib149","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/ejhpharm-2020-002433","article-title":"Incidence and associated risk factors of antituberculosis drug-induced hepatotoxicity among hospitalised patients in Wuhan, China","volume":"29","author":"Xu","year":"2022","journal-title":"Eur J Hosp Pharm Sci Pract"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib150","first-page":"227","article-title":"[Association between isoniazid induced hepatotoxicity and host N-acetyltransferase 2 polymorphisms]","volume":"45","author":"Yang","year":"2022","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib151","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/JCMA.0000000000000605","article-title":"Hepatotoxicity, efficacy and completion rate between 3 months of isoniazid plus rifapentine and 9 months of isoniazid in treating latent tuberculosis infection: a systematic review and meta-analysis","volume":"84","author":"Tseng","year":"2021","journal-title":"J\u00a0Chin Med Assoc"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib152","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1002\/ptr.7517","article-title":"Gut microbiota, bile acids, and nature compounds","volume":"36","author":"Cheng","year":"2022","journal-title":"Phytother Res"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib153","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.trsl.2016.08.002","article-title":"Gut microbiome interactions with drug metabolism, efficacy, and toxicity","volume":"179","author":"Wilson","year":"2017","journal-title":"Transl Res"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib154","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/phar.2650","article-title":"Role of the gut microbiome in cardiovascular drug response: the potential for clinical application","volume":"42","author":"Steiner","year":"2022","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib155","first-page":"317","article-title":"Gut microbiota associated with pulmonary tuberculosis and dysbiosis caused by anti-tuberculosis drugs","volume":"78","author":"Hu","year":"2019","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib156","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s40168-017-0286-2","article-title":"Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy","volume":"5","author":"Namasivayam","year":"2017","journal-title":"Microbiome"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib157","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12866-023-02801-4","article-title":"Gut microbiota characteristics of Mongolian and Han populations in anti-tuberculosis drug-induced liver injury: a population-based case-control study","volume":"23","author":"Hao","year":"2023","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib158","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.3390\/nu9111220","article-title":"Nonalcoholic fatty liver disease is exacerbated in high-fat diet-fed gnotobiotic mice by colonization with the gut microbiota from patients with nonalcoholic steatohepatitis","volume":"9","author":"Chiu","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib159","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4314\/ejhs.v27i2.3","article-title":"Hepatotoxicity due to antituberculosis therapy among paediatric patients seen at the University of Ilorin Teaching Hospital, North Central Nigeria","volume":"27","author":"Aishatu","year":"2017","journal-title":"Ethiop J Health Sci"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1471-230X-10-93","article-title":"Acute-on-chronic liver failure due to thiamazole in a patient with hyperthyroidism and trilogy of Fallot: case report","volume":"10","author":"Shen","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib161","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4103\/2230-8210.152766","article-title":"Anti-thyroid drugs in pediatric Graves\u2019 disease","volume":"19","author":"John","year":"2015","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib162","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1007\/s10620-014-3389-7","article-title":"Acute liver failure: a potential complication of antithyroid medication use","volume":"60","author":"Chou","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib163","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12876-022-02133-z","article-title":"Graves\u2019 disease overlapping with chronic hepatitis B and methimazole-induced liver injury and autoimmune hepatitis: a case report","volume":"22","author":"Zheng","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib164","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/bcp.12336","article-title":"Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study","volume":"78","author":"Wang","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib165","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1089\/thy.2014.0350","article-title":"Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China","volume":"25","author":"Yang","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib166","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/934726","article-title":"Unusual synchronous methimazole-induced agranulocytosis and severe hepatotoxicity in patient with hyperthyroidism: a case report and review of the literature","volume":"2015","author":"Yang","year":"2015","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib167","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1210\/jc.2010-1141","article-title":"Propylthiouracil-induced hepatotoxicity and death. Hopefully, never more","volume":"95","author":"Malozowski","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib168","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s40168-018-0478-4","article-title":"Gut microbiota in experimental murine model of Graves\u2019 orbitopathy established in different environments may modulate clinical presentation of disease","volume":"6","author":"Masetti","year":"2018","journal-title":"Microbiome"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib169","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s40618-019-1010-9","article-title":"Alterations in the intestinal microbiota of patients with severe and active Graves\u2019 orbitopathy: a cross-sectional study","volume":"42","author":"Shi","year":"2019","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib170","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.7150\/ijbs.24151","article-title":"Molecular alteration analysis of human gut microbial composition in Graves\u2019 disease patients","volume":"14","author":"Ishaq","year":"2018","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib171","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1530\/EC-19-0001","article-title":"Alteration of the intestinal flora may participate in the development of Graves\u2019 disease: a study conducted among the Han population\u00a0in southwest China","volume":"8","author":"Yang","year":"2019","journal-title":"Endocr Connect"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib172","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3389\/fmicb.2017.01523","article-title":"Protection mechanism of Clostridium butyricum against Salmonella enteritidis infection in broilers","volume":"8","author":"Zhao","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib173","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.3390\/ijms19082212","article-title":"Hepatoprotective effects of lactobacillus on carbon tetrachloride-induced acute liver injury in mice","volume":"19","author":"Chen","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib174","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3390\/nu10070810","article-title":"Combined use of C. butyricum Sx-01 and L. salivarius C-1-3 improves intestinal health and reduces the amount of lipids in serum via modulation of gut microbiota in mice","volume":"10","author":"Long","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.jcmgh.2024.05.003_bib175","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-0042-118170","article-title":"Impact of the herbal breviscapine on the pharmacokinetics of simvastatin in rats: the involvement of CYP3A4","volume":"67","author":"Ju","year":"2017","journal-title":"Drug Res"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X24001097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X24001097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:09:57Z","timestamp":1729123797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X24001097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":171,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"alternative-id":["S2352345X24001097"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2024.05.003","relation":{},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interplay Between Drug-Induced Liver Injury and Gut Microbiota: A Comprehensive Overview","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2024.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}],"article-number":"101355"}}